Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | PRKCI | P41743 | 5/20 | 0.40 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.39 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.39 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.39 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5410532 | 0.89 | MAPT (0.46) | MAPTSMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL5402116 | 0.87 | MAPT (0.47) | MAPTSMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL5412840 | 0.86 | MAPT (0.46) | MAPTSMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL5413011 | 0.86 | ALDH1A1 (0.46) | MAPTSMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL5408026 | 0.85 | MAPT (0.51) | MAPTSMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL5407504 | 0.84 | MAPT (0.47) | MAPTSMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL5408437 | 0.83 | MAPT (0.44) | MAPTSMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL6706633 | 0.83 | MAPT (0.47) | MAPTSMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL6711489 | 0.83 | SMN1; SMN2 (0.49) | MAPTSMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL5408444 | 0.82 | MEN1 (0.58) | MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7259168-B2 | 2-Aminoalkyl-thieno[2,3-d]pyrimidines | MERCK PATENT GMBH (DE) | 2007-08-21 | — | — | US | claimed |
| EP-1294729-B1 | 2-AMINOALKYL-THIENO[2,3-D]PYRIMIDINES | MERCK PATENT GMBH (DE) | 2004-09-15 | — | — | EP | claimed |
| US-20040044011-A1 | 2-Aminoalkyl-thieno[2,3-d]pyrimidines | MEREK PATENT GMBH (DE) | 2004-03-04 | — | — | US | claimed |
| EP-1294729-A1 | 2-AMINOALKYL-THIENO[2,3-D]PYRIMIDINES | MERCK PATENT GmbH (DE) | 2003-03-26 | — | — | EP | claimed |
| WO-2002000664-A1 | 2-AMINOALKYL-THIENO[2,3-D]PYRIMIDINES | MERCK PATENT GMBH (DE) | 2002-01-03 | — | — | WO | claimed |
| US-7259168-B2 | 2-Aminoalkyl-thieno[2,3-d]pyrimidines | MERCK PATENT GMBH (DE) | 2007-08-21 | — | — | US | disclosed |
| EP-1294729-B1 | 2-AMINOALKYL-THIENO[2,3-D]PYRIMIDINES | MERCK PATENT GMBH (DE) | 2004-09-15 | — | — | EP | disclosed |
| US-20040044011-A1 | 2-Aminoalkyl-thieno[2,3-d]pyrimidines | MEREK PATENT GMBH (DE) | 2004-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040044011-A1 | 2-Aminoalkyl-thieno[2,3-d]pyrimidines | DPYD, PDE3A, PDE2A | MAPT 4740/4885SMN1; SMN2 2219/4885MEN1 4344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.